Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Chen, Mei ^a   Forrester, John V ^b   Xu, Heping ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3D; COMPLEMENT MEMBRANE ATTACK COMPLEX; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, MOUSE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL DEATH; CHEMOTAXIS; CHOROID; CHRONIC STRESS; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; INNATE IMMUNITY; MICROGLIA; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHOTORECEPTOR CELL; PIGMENT CELL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RETINA DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS; WILD TYPE; ANIMAL; AUTOIMMUNE DISEASE; DENDRITIC CELL; FEMALE; GENETICS; METABOLISM; MONONUCLEAR CELL; MOUSE MUTANT; PATHOLOGY; PIGMENT EPITHELIUM; RETINA; RETINA DISEASE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

MUS;

ANIMALS; AUTOIMMUNE DISEASES; CHEMOKINE CCL2; DENDRITIC CELLS; FEMALE; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CCR2; RETINA; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79961159284     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022818     Document Type: Article

References (45)

1. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (4): 564-572.
2. Coleman HR, Chan CC, Ferris FL 3rd, Chew EY, (2008) Age-related macular degeneration. Lancet 372 (9652): 1835-1845.
3. Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, et al. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group (2006) Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113 (9): 1508.e1-1508.25.
4. Hughes MS, Sang DN, (2006) Safety and efficacy of intravitreal bevacizumab followed by pegaptanib maintenance as a treatment regimen for age-related macular degeneration. Ophthalmic Surg Lasers Imaging 37 (6): 446-454.
5. Bressler NM, Chang TS, Fine JT, Dolan CM, Ward J, et al. (2009) Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. Arch Ophthalmol 127 (1): 13-21.
6. Chakravarthy U, Augood C, Bentham GC, de Jong PT, Rahu M, et al. (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114 (6): 1157-1163.
7. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, et al. (2005) Smoking and age-related macular degeneration: a review of association. Eye 19 (9): 935-944.
8. Kaushik S, Wang JJ, Flood V, Tan JS, Barclay AW, et al. (2008) Dietary glycemic index and the risk of age-related macular degeneration. Am J Clin Nutr 88 (4): 1104-1110.
9. Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, et al. (2008) Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 115 (2): 334-341.
10. Margrain TH, Boulton M, Marshall J, Sliney DH, (2004) Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res 23 (5): 523-531.
11. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308 (572): 385-389.
12. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (572): 419-421.
13. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, et al. (2007) Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 16 (16): 1986-1992.
14. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308 (572): 421-424.
15. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) From The Cover: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. PNAS 102 (2): 7227-7232.
16. Tuo J, Smith BC, Bojanowski CM, Meleth AD, Gery I, et al. (2004) The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 18 (11): 1297-1299.
17. Harman D, (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11 (3): 298-300.
18. Medzhitov R, (2008) Origin and physiological roles of inflammation. Nature 454 (7203): 428-435.
19. Xu H, Chen M, Forrester JV, (2009) Para-inflammation in the aging retina. Prog Retin Eye Res 28 (5): 348-368.
20. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, et al. (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9 (1): 1390-1397.
21. Combadiere C, Feumi C, Raoul W, Keller N, Rodero M, et al. (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117 (10): 2920-2928.
22. Tuo J, Bojanowski CM, Zhou M, Shen D, Ross RJ, et al. (2007) Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci 48 (8): 3827-3836.
23. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, et al. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187 (4): 601-608.
24. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, et al. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100 (10): 2552-2561.
25. Xu H, Koch P, Chen M, Lau A, Reid DM, et al. (2008) A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp Eye Res 87 (4): 319-326.
26. Paques M, Guyomard JL, Simonutti M, Roux MJ, Picaud S, et al. (2007) Panretinal, high-resolution color photography of the mouse fundus. Invest Ophthalmol Vis Sci 48 (6): 2769-2774.
27. Xu H, Chen M, Manivannan A, Lois N, Forrester JV, (2008) Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 7 (1): 58-68.
28. Xu H, Manivannan A, Goatman KA, Liversidge J, Sharp PF, et al. (2002) Improved Leukocyte Tracking in Mouse Retinal and Choroidal Circulation. Exp Eye Res pp. 74403-410.
29. Xu H, Manivannan A, Goatman KA, Jiang HR, Liversidge J, et al. (2004) Reduction in shear stress, activation of the endothelium, and leukocyte priming are all required for leukocyte passage across the blood-retina barrier. J Leukoc Biol pp. 75224-232.
30. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods pp. 22377-92.
31. Jiang HR, Muckersie E, Robertson M, Xu H, Liversidge J, et al. (2002) Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture. J Leukoc Biol 72 (5): 978-985.
32. Chen M, Muckersie E, Robertson M, Fraczek M, Forrester JV, et al. (2008) Characterization of a spontaneous mouse retinal pigment epithelial cell line B6-RPE07. Invest Ophthalmol Vis Sci 49 (8): 3699-3706.
33. Chen M, Forrester JV, Xu H, (2007) Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp Eye Res pp. 84635-645.
34. Chen M, Muckersie E, Luo C, Forrester JV, Xu H, (2010) Inhibition of the alternative pathway of complement activation reduces inflammation in experimental autoimmune uveoretinitis. Eur J Immunol 40 (10): 2870-2881.
35. Copland DA, Hussain K, Baalasubramanian S, Hughes TR, Morgan BP, et al. (2010) Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol 159 (3): 303-314.
36. Read RW, Szalai AJ, Vogt SD, McGwin G, Barnum SR, (2006) Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis. Exp Eye Res 82 (3): 389-394.
37. Chan-Ling T, Hughes S, Baxter L, Rosinova E, McGregor I, et al. (2007) Inflammation and breakdown of the blood-retinal barrier during "physiological aging" in the rat retina: a model for CNS aging. Microcirculation 14 (1): 63-76.
38. Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, et al. (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 50 (12): 5934-5943.
39. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, et al. (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29 (2): 95-112.
40. Chen M, Muckersie E, Robertson M, Forrester JV, Xu H, (2008) Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp Eye Res 87 (6): 543-550.
41. Ng TF, Streilein JW, (2001) Light-Induced Migration of Retinal Microglia into the Subretinal Space. Invest Ophthalmol Vis Sci 42 (1): 3301-3310.
42. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA, (2009) An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A 106 (44): 18751-18756.
43. Randolph GJ, (2001) Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin Immunol 13 (5): 267-274.
44. Raoul W, Keller N, Rodero M, Behar-Cohen F, Sennlaub F, et al. (2008) Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells. J Neuroimmunol 198 (1-2): 56-61.
45. Despriet DD, Bergen AA, Merriam JE, Zernant J, Barile GR, et al. (2008) Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration. Invest Ophthalmol Vis Sci 49 (1): 364-371.